Your browser is no longer supported. Please, upgrade your browser.
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E20.64 EPS (ttm)2.19 Insider Own0.04% Shs Outstand5.60B Perf Week4.00%
Market Cap252.84B Forward P/E12.85 EPS next Y3.52 Insider Trans-0.24% Shs Float5.59B Perf Month15.02%
Income12.40B PEG1.76 EPS next Q1.06 Inst Own66.70% Short Float1.10% Perf Quarter13.06%
Sales55.52B P/S4.55 EPS this Y-33.10% Inst Trans0.14% Short Ratio2.35 Perf Half Y29.71%
Book/sh12.29 P/B3.68 EPS next Y-12.01% ROA5.80% Target Price42.97 Perf Year24.21%
Cash/sh2.44 P/C18.50 EPS next 5Y11.70% ROE14.70% 52W Range32.79 - 45.86 Perf YTD22.77%
Dividend1.56 P/FCF68.13 EPS past 5Y2.20% ROI7.60% 52W High-1.46% Beta0.73
Dividend %3.45% Quick Ratio1.20 Sales past 5Y-3.00% Gross Margin74.70% 52W Low37.82% ATR0.78
Employees78500 Current Ratio1.50 Sales Q/Q44.60% Oper. Margin14.60% RSI (14)77.33 Volatility2.13% 1.69%
OptionableYes Debt/Eq0.58 EPS Q/Q95.10% Profit Margin17.30% Rel Volume1.65 Prev Close45.68
ShortableYes LT Debt/Eq0.52 EarningsJul 28 BMO Payout87.90% Avg Volume26.07M Price45.19
Recom2.60 SMA209.42% SMA5012.73% SMA20020.11% Volume43,034,549 Change-1.07%
Jul-27-21Resumed Truist Buy $43
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Aug-04-21 09:01PM  
03:39PM  
03:07PM  
02:12PM  
01:46PM  
01:18PM  
12:28PM  
11:19AM  
11:04AM  
10:43AM  
09:34AM  
09:23AM  
06:45AM  
06:37AM  
06:33AM  
06:02AM  
03:08AM  
01:58AM  
Aug-03-21 09:58PM  
08:16PM  
08:10PM  
06:00PM  
05:57PM  
05:47PM  
05:38PM  
04:23PM  
03:28PM  
02:45PM  
02:25PM  
12:39PM  
11:49AM  
10:59AM  
10:09AM  
08:38AM  
07:22AM  
05:52AM  
03:54AM  
02:45AM  
Aug-02-21 07:34PM  
06:18PM  
05:21PM  
04:50PM  
04:29PM  
03:55PM  
03:10PM  
02:28PM  
01:55PM  
01:48PM  
01:05PM  
12:50PM  
12:05PM  
12:02PM  
11:31AM  
10:41AM  
10:09AM  
09:22AM  
08:42AM  
08:20AM  
08:08AM  
04:46AM  
04:00AM  
03:50AM  
03:20AM  
02:34AM  
Aug-01-21 09:00PM  
04:34PM  
11:31AM  
09:34AM  
08:14AM  
07:40AM  
06:33AM  
06:00AM  
05:52AM  
Jul-31-21 01:25PM  
09:12AM  
09:02AM  
Jul-30-21 09:32PM  
03:08PM  
02:17PM  
01:56PM  
01:34PM  
12:31PM  
11:28AM  
10:14AM  
10:12AM  
09:41AM  
08:00AM  
07:09AM  
06:02AM  
06:00AM  
05:52AM  
05:25AM  
Jul-29-21 05:55PM  
04:44PM  
02:27PM  
02:06PM  
12:15PM  
11:18AM  
11:03AM  
10:16AM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerJul 30Sale42.862,500107,15011,430Aug 02 07:02 PM
DAMICO JENNIFER B.SVP & ControllerMay 05Sale40.822,500102,05013,748May 07 04:10 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5413,000501,08513,000Aug 10 08:07 AM